Immediate Impact

32 standout
Sub-graph 1 of 16

Citing Papers

Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials
2024 Standout
Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes
2024 Standout
2 intermediate papers

Works of Julie Mount being referenced

Cardiovascular risk profiles: A cross‐sectional study evaluating the generalizability of the glucagon‐like peptide‐1 receptor agonist cardiovascular outcome trials REWIND , LEADER and SUSTAIN ‐6 to the real‐world type 2 diabetes population in the United Kingdom
2021
Disparities in glycaemic control, monitoring, and treatment of type 2 diabetes in England: A retrospective cohort analysis
2019

Author Peers

Author Last Decade Papers Cites
Julie Mount 74 89 26 72 38 368
Fatma A. Hegazy 30 52 3 44 38 359
Phillip R. Bryant 42 45 6 58 33 369
A. Yelnik 19 132 13 93 34 390
Ali Asghar Arastoo 32 156 12 70 21 401
Fatma Uygur 35 109 31 71 33 405
İbrahim Engin Şimşek 33 95 15 53 23 378
Mário Oliveira Lima 20 132 2 82 44 349
R Wallace 65 72 19 20 47 391
Prasath Jayakaran 49 75 62 58 29 346
Yoon Ghil Park 28 42 5 67 48 408

All Works

Loading papers...

Rankless by CCL
2026